Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad H Stopsack

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Prostate Cancer and Prostatic Diseases|March 30, 2021
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studiesEmma H Allott, Emma L Craig, Konrad H Stopsack
Neurocase|April 6, 2017
A formal analysis of alexia in persistent aura and a comparison to acquired pure alexiaTobias Bormann, Konrad H Stopsack, Irina Mader, et al.
Cancer Causes & Control : CCC|November 6, 2015
Metformin and prostate cancer mortality: a meta-analysisKonrad H Stopsack, David R Ziehr, Jennifer R Rider, et al.
The Journal of Urology|December 1, 2022
Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate CancerYiwen Zhang, Konrad H Stopsack, Kana Wu, et al.
British Journal of Cancer|March 16, 2024
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancerYiwen Zhang, Konrad H Stopsack, Kana Wu, et al.
Cancer Discovery|April 12, 2020
<i>TMPRSS2</i> and COVID-19: Serendipity or Opportunity for Intervention?Konrad H Stopsack, Lorelei A Mucci, Emmanuel S Antonarakis, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 9, 2018
Psoriasin, a novel anti-Candida albicans adhesinAnnelie Brauner, Cathrin Alvendal, Milan Chromek, et al.
American Journal of Hematology|March 2, 2016
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-AnalysisNatasha Kekre, Kimberley S Mak, Konrad H Stopsack, et al.
European Urology Oncology|December 31, 2021
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-upKonrad H Stopsack, Daniela Correia Salles, J Bailey Vaselkiv, et al.
Journal of the National Cancer Institute|August 29, 2020
Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate CancerJoshua Z Drago, Mithat Gönen, Gita Thanarajasingam, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Prostate Cancer and Prostatic Diseases|March 30, 2021
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studiesEmma H Allott, Emma L Craig, Konrad H Stopsack
Neurocase|April 6, 2017
A formal analysis of alexia in persistent aura and a comparison to acquired pure alexiaTobias Bormann, Konrad H Stopsack, Irina Mader, et al.
Cancer Causes & Control : CCC|November 6, 2015
Metformin and prostate cancer mortality: a meta-analysisKonrad H Stopsack, David R Ziehr, Jennifer R Rider, et al.
The Journal of Urology|December 1, 2022
Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate CancerYiwen Zhang, Konrad H Stopsack, Kana Wu, et al.
British Journal of Cancer|March 16, 2024
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancerYiwen Zhang, Konrad H Stopsack, Kana Wu, et al.
Cancer Discovery|April 12, 2020
<i>TMPRSS2</i> and COVID-19: Serendipity or Opportunity for Intervention?Konrad H Stopsack, Lorelei A Mucci, Emmanuel S Antonarakis, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 9, 2018
Psoriasin, a novel anti-Candida albicans adhesinAnnelie Brauner, Cathrin Alvendal, Milan Chromek, et al.
American Journal of Hematology|March 2, 2016
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-AnalysisNatasha Kekre, Kimberley S Mak, Konrad H Stopsack, et al.
European Urology Oncology|December 31, 2021
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-upKonrad H Stopsack, Daniela Correia Salles, J Bailey Vaselkiv, et al.
Journal of the National Cancer Institute|August 29, 2020
Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate CancerJoshua Z Drago, Mithat Gönen, Gita Thanarajasingam, et al.
Pageof 11